Evidence map›Paper›PMID 23816641›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2013

Proteolytically activated anti-bacterial hydrogel microspheres.

Jason S Buhrman, Laura C Cook, Jamie E Rayahin, Michael J Federle, Richard A Gemeinhart

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Research progress on blood compatibility of hemoperfusion adsorbent materials.Frontiers in bioengineering and biotechnology · 2024
    Review
  2. Assessment of antibiotic release and antibacterial efficacy from pendant glutathione hydrogels using ex vivo porcine skin.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Article
  3. Article
  4. Antibacterial Hydrogels.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2018
    Review
  5. Review
  6. Article
  7. Melittin-glutathione S-transferase fusion protein exhibits anti-inflammatory properties and minimal toxicity.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2014
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jason S BuhrmanDepartment of Biopharmaceutical Sciences, University of Illinois, Chicago, IL 60612-7231, USA.
Laura C Cook
Jamie E Rayahin
Michael J Federle
Richard A Gemeinhart
University of Illinois Chicago · USUniversity of Illinois Urbana-Champaign · US

Funding

Center for Clinical and Translational ScienceUL1TR000050 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI AZAR, DIMITRI T, MERMELSTEIN, ROBIN J. · 2012 to 2014
$9.8M
Mechanistic Dissection of Pheromone-Dependent Regulation of Group A StreptococcalR01AI091779 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FEDERLE, MICHAEL J · 2011 to 2021
$3.9M
Understanding and Preventing Tumor Disperal with Hydrogel TherapeuticsR01NS055095 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GEMEINHART, RICHARD A · 2007 to 2011
$1.7M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR015482 · NCRR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BAUMAN, JERRY L · 2000 to 2000
$909k
NCATS NIH HHS UL1 TR000050NCRR NIH HHS C06 RR015482NCRR NIH HHS RR15482NIAID NIH HHS AI091779NIAID NIH HHS R01 AI091779NINDS NIH HHS NS055095NINDS NIH HHS R01 NS055095
6 · The paper itself

Abstract

Hydrogels are finding increased clinical utility as advances continue to exploit their favorable material properties. Hydrogels can be adapted for many applications, including surface coatings and drug delivery. Anti-infectious surfaces and delivery systems that actively destroy invading organisms are alternative ways to exploit the favorable material properties offered by hydrogels. Sterilization techniques are commonly employed to ensure the materials are non-infectious upon placement, but sterilization is not absolute and infections are still expected. Natural, anti-bacterial proteins have been discovered which have the potential to act as anti-infectious agents; however, the proteins are toxic and need localized release to have therapeutic efficacy without toxicity. In these studies, we explore the use of the glutathione s-transferase (GST) to anchor the bactericidal peptide, melittin, to the surface of poly(ethylene glycol) diacrylate (PEGDA) hydrogel microspheres. We show that therapeutic levels of protein can be anchored to the surface of the microspheres using the GST anchor. We compared the therapeutic efficacy of recombinant melittin released from PEGDA microspheres to melittin. We found that, when released by an activating enzyme, thrombin, recombinant melittin efficiently inhibits growth of the pathogenic bacterium Streptococcus pyogenes as effectively as melittin created by solid phase peptide synthesis. We conclude that a GST protein anchor can be used to immobilize functional protein to PEGDA microspheres and the protein will remain immobilized under physiological conditions until the protein is enzymatically released.

Indexed as

Anti-Bacterial AgentsDrug CarriersGlutathione TransferaseHumansHydrogel, Polyethylene Glycol DimethacrylateMelittenMicrospheresModels, MolecularPolyethylene GlycolsProteolysisRecombinant ProteinsStreptococcal InfectionsStreptococcus pyogenesThrombinAnti-Bacterial AgentsDrug CarriersGlutathione TransferaseHydrogel, Polyethylene Glycol DimethacrylateMelittenpoly(ethylene glycol)diacrylatePolyethylene GlycolsRecombinant ProteinsThrombinGlutathioneGlutathione s-transferaseHydrogelMicroparticlesRecombinant proteinThrombin

Identifiers

PMID23816641
PMCPMC3795988
OpenAlexW2086546207

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.